Join Bristol Myers Squibb, Genentech, Google, J.P. Morgan, Novo Nordisk, Pappas Capital, Amazon Web Services, BIO, Members of ...

Transpire Bio announced today that its Chief Executive Officer, Dr. Xian-Ming Zeng, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 15, 2026 at ...

The most notable strategic choice is prioritising myasthenia gravis (MG) and Sjögren's disease as lead indications while ...

FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare ...

For more information, please visit the conference website here.

Major Korean biopharmaceutical firms are gearing up to showcase their vision and strengths at the 44th J.P. Morgan Healthcare ...

Immorta Bio Inc., a scientific longevity company dedicated to Treating Diseases of Aging and Treating Aging as Disease(TM), today announced new data demonstrating that its combination therapy of ...

Biopharmaceutical company Rakuten announced the signing of a manufacturing partnership with contract development and ...

The world's largest bio investment event, the JP Morgan Healthcare Conference (JPMHC), is just a week away. With the total ...

BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced ...

SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte ...

Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced that Nate Fernhoff, Ph.D., Orca Bio’s co-founder and ...